Bank of New York Mellon’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43M | Buy |
542,454
+27,837
| +5% | +$2.09M | 0.01% | 1165 |
|
|
2026
Q1 | $38.6M | Sell |
514,617
-23,269
| -4% | -$1.84M | 0.01% | 1148 |
|
|
2025
Q4 | $42.6M | Buy |
537,886
+5,772
| +1% | +$435K | 0.01% | 1102 |
|
|
2025
Q3 | $34.8M | Buy |
532,114
+4,926
| +0.9% | +$241K | 0.01% | 1228 |
|
|
2025
Q2 | $20.8M | Sell |
527,188
-17,445
| -3% | -$571K | ﹤0.01% | 1492 |
|
|
2025
Q1 | $16.4M | Sell |
544,633
-71,438
| -12% | -$2.34M | ﹤0.01% | 1601 |
|
|
2024
Q4 | $21.5M | Buy |
616,071
+5,178
| +0.8% | +$194K | ﹤0.01% | 1523 |
|
|
2024
Q3 | $24.5M | Buy |
610,893
+13,414
| +2% | +$624K | ﹤0.01% | 1461 |
|
|
2024
Q2 | $28.5M | Buy |
597,479
+13,890
| +2% | +$570K | 0.01% | 1372 |
|
|
2024
Q1 | $25.3M | Sell |
583,589
-57,474
| -9% | -$2.74M | ﹤0.01% | 1440 |
|
|
2023
Q4 | $32.4M | Buy |
641,063
+13,904
| +2% | +$666K | 0.01% | 1330 |
|
|
2023
Q3 | $28.4M | Buy |
627,159
+69,405
| +12% | +$2.86M | 0.01% | 1344 |
|
|
2023
Q2 | $22.9M | Sell |
557,754
-8,341
| -1% | -$321K | ﹤0.01% | 1466 |
|
|
2023
Q1 | $20.2M | Sell |
566,095
-7,703
| -1% | -$289K | ﹤0.01% | 1536 |
|
|
2022
Q4 | $21.7M | Sell |
573,798
-5,615
| -1% | -$236K | ﹤0.01% | 1485 |
|
|
2022
Q3 | $25.6M | Sell |
579,413
-85,903
| -13% | -$3.62M | 0.01% | 1353 |
|
|
2022
Q2 | $24.6M | Buy |
665,316
+116,069
| +21% | +$4.38M | 0.01% | 1428 |
|
|
2022
Q1 | $20.3M | Sell |
549,247
-7,330
| -1% | -$240K | ﹤0.01% | 1670 |
|
|
2021
Q4 | $16.9M | Sell |
556,577
-3,989
| -0.7% | -$126K | ﹤0.01% | 1818 |
|
|
2021
Q3 | $18.8M | Buy |
560,566
+20,037
| +4% | +$755K | ﹤0.01% | 1757 |
|
|
2021
Q2 | $21.6M | Sell |
540,529
-4,569
| -0.8% | -$179K | ﹤0.01% | 1690 |
|
|
2021
Q1 | $24.5M | Sell |
545,098
-24,896
| -4% | -$1.39M | 0.01% | 1588 |
|
|
2020
Q4 | $32.2M | Buy |
569,994
+22,638
| +4% | +$1.13M | 0.01% | 1330 |
|
|
2020
Q3 | $26M | Sell |
547,356
-7,705
| -1% | -$428K | 0.01% | 1299 |
|
|
2020
Q2 | $32.7M | Buy |
555,061
+1,091
| +0.2% | +$60.7K | 0.01% | 1138 |
|
|
2020
Q1 | $26.2M | Sell |
553,970
-19,804
| -3% | -$1.1M | 0.01% | 1129 |
|
|
2019
Q4 | $34.7M | Buy |
573,774
+26,539
| +5% | +$1.58M | 0.01% | 1214 |
|
|
2019
Q3 | $32.8M | Buy |
547,235
+1,800
| +0.3% | +$117K | 0.01% | 1216 |
|
|
2019
Q2 | $35.1M | Buy |
545,435
+26,378
| +5% | +$1.86M | 0.01% | 1195 |
|
|
2019
Q1 | $42.1M | Sell |
519,057
-11,225
| -2% | -$724K | 0.01% | 1067 |
|
|
2018
Q4 | $28.7M | Buy |
530,282
+2,380
| +0.5% | +$121K | 0.01% | 1250 |
|
|
2018
Q3 | $27.2M | Buy |
527,902
+8,741
| +2% | +$411K | 0.01% | 1424 |
|
|
2018
Q2 | $21.6M | Sell |
519,161
-23,086
| -4% | -$1.02M | 0.01% | 1553 |
|
|
2018
Q1 | $23.9M | Buy |
542,247
+1,370
| +0.3% | +$69.6K | 0.01% | 1447 |
|
|
2017
Q4 | $27.2M | Buy |
540,877
+1,430
| +0.3% | +$78.4K | 0.01% | 1394 |
|
|
2017
Q3 | $27.3M | Buy |
539,447
+11,447
| +2% | +$600K | 0.01% | 1376 |
|
|
2017
Q2 | $26.9M | Sell |
528,000
-1,657
| -0.3% | -$77.2K | 0.01% | 1357 |
|
|
2017
Q1 | $21.3M | Buy |
529,657
+10,967
| +2% | +$493K | 0.01% | 1513 |
|
|
2016
Q4 | $24.8M | Buy |
518,690
+30,821
| +6% | +$1.22M | 0.01% | 1403 |
|
|
2016
Q3 | $17.9M | Sell |
487,869
-73,966
| -13% | -$2.31M | 0.01% | 1525 |
|
|
2016
Q2 | $13.1M | Sell |
561,835
-3,336
| -0.6% | -$108K | ﹤0.01% | 1699 |
|
|
2016
Q1 | $22.9M | Buy |
565,171
+6,171
| +1% | +$251K | 0.01% | 1320 |
|
|
2015
Q4 | $34.6M | Buy |
559,000
+393
| +0.1% | +$21.2K | 0.01% | 1042 |
|
|
2015
Q3 | $22.6M | Sell |
558,607
-1,621
| -0.3% | -$83.9K | 0.01% | 1349 |
|
|
2015
Q2 | $32.2M | Sell |
560,228
-210,001
| -27% | -$13.4M | 0.01% | 1164 |
|
|
2015
Q1 | $49M | Buy |
770,229
+55,779
| +8% | +$3.78M | 0.01% | 910 |
|
|
2014
Q4 | $44.1M | Sell |
714,450
-12,225
| -2% | -$603K | 0.01% | 958 |
|
|
2014
Q3 | $28.2M | Sell |
726,675
-2,658
| -0.4% | -$94.2K | 0.01% | 1211 |
|
|
2014
Q2 | $25.1M | Buy |
729,333
+55,628
| +8% | +$1.75M | 0.01% | 1327 |
|
|
2014
Q1 | $29.1M | Buy |
673,705
+21,043
| +3% | +$1.02M | 0.01% | 1229 |
|
|
2013
Q4 | $26M | Sell |
652,662
-503
| -0.1% | -$17.9K | 0.01% | 1297 |
|
|
2013
Q3 | $24.5M | Sell |
653,165
-1,540
| -0.2% | -$46K | 0.01% | 1273 |
|
|
2013
Q2 | $17.6M | Buy |
+654,705
| New | +$13.9M | 0.01% | 1461 |
|
Other funds holding IONS
TBC
TCM
PA
CWG
Bank of New York Mellon's IONS Position: Q2 2026 in Review
Bank of New York Mellon increased its Ionis Pharmaceuticals (IONS) stake by 5.4% in Q2 2026, buying an estimated $2.09M and bringing the position to 542,454 shares worth $43M. The position accounts for 0.01% of the portfolio, ranked #1165.
Bank of New York Mellon first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. The position peaked at $49M in Q1 2015. 241 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Bank of New York Mellon held 542,454 shares of Ionis Pharmaceuticals worth $43M as of Q2 2026.
- Bank of New York Mellon bought 27,837 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.09M.
- Ionis Pharmaceuticals made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1165 holding.
- Bank of New York Mellon first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Ionis Pharmaceuticals position peaked at $49M in Q1 2015.
- 241 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.